09.00 Pharma IQ’s And Chair’s Welcome

Dr Fadel Hamed
Associate Director, Head of Operational Excellence
Genentech

09.15 Opening Keynote: Gaining Senior Level Buy In And Executive Support

• Driving operational excellence from an executive level to cement change
• Identification of the major success drivers for further deployment
• Sustaining investments and translating this to real improvements
• Effectively utilising people within your organisation

Jennifer Miller
Executive Director, Global Research and Development
Pfizer

10.00 6 Sigma Program Deployment: 2 Years Later Reaping Rewards In Manufacturing

• Abbott Clonmel 6 Sigma programme roll out: Why it has worked for us
• Deciding upon the program structure suitable for Abbott
• Case study: successes and pitfalls along the way, what would we have done differently

Michael Cummane
Business Excellence Manager
Abbott Vascular

11.15 Operational Excellence Project Valuation In The Presence Of Volume Variations In The Pharmaceutical Industry

• Contrasting direct and indirect benefits
• When does indirect become direct?
• What is the value of Soft benefits?
• When does over focus on hard benefit become a liability?

Brian Eden
Senior Director, Global Operational Excellence
Mylan

12.00 Successful Strategy Execution: How To Minimise Failure Of Strategic Initiatives

• Effective operational excellence cannot be realised unless a company can formulate and successfully execute the right strategies
• Most strategies formulated by companies around the globe today fail to realise their original purpose and intent
• Understanding the risks associated with successful execution of the strategy can enable companies to increase the probability of successfully launching and benefiting from strategic initiatives

Dr Fadel Hamed
Associate Director, Head of Operational Excellence
Genentech

14.00 Practical Implementation Of Advanced Analytical Technologies To Achieve Meaningful Manufacturing Optimisation

• Why optimisation of a process at a unit operation level is most likely to deliver measurable business benefit
• An overview of the challenges in identifying and solving issues relating to implementing unit operation optimisation
• An alternative approach to solution development
• Regulatory concerns with changes in manufacturing processes
• How manufacturing optimisation can be addressed within current regulatory compliance guidance
• An overview of a structured process to address compliance concerns in implementing unit optimisation projects with advanced analytics

14.45 Strategy Deployment: Implementing A Robust Strategy For Continuous Improvement

• Practical guidelines for strategy deployment in a manufacturing site
• Embedding core values and aligning a focus within the organization to drive continuous improvement
• Lessons learned for future deployment of strategy

Alexander Herget
Director, Manufacturing Orth and Strategy Deployment Central Europe
Baxter

16.00 How Does Pharma Cope With The Changing Environment?

• The different levels of PAT and how to implement them into your production process?
• How to make quality an integrated part of your manufacturing?
• Key drivers and business benefits: what is the true gain of PAT?
• Somen convincing business cases

Rebecca Vangenechten
Consultant Innovative Technologies
Siemens Industry & Automation

16.45 PAT Development And Deployment In An R&D Environment

• Drivers for developing PAT approaches
• Risk assessment and development of process understanding through PAT
• PAT based experimental assessments

Dr Ian Clegg
Head of PAT
Pfizer

17.30 Rediscovering The Research Engine

• Introducing Lean To A Research Organisation. Background, Culture And Strategy
• Adapting Lean To Research - And Research To Lean!
• Building A Process Data Infrastructure
• Process Data As A Key Lever For Merging Science And Lean Aspirations

Dr Anders Kanstrup
Principal Scientist - CLEAN® Internal Consultant
Novo Nordisk

18.15 Chair’s Closing Remarks and end of day one